Publicacións en colaboración con investigadores/as de Universitat de Barcelona (18)

2023

  1. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  2. Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 455-467

  2. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

    Pathogens, Vol. 11, Núm. 10

  3. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

    Microbiology Spectrum, Vol. 10, Núm. 3

  4. Risk Factors of DAIR Failure and Validation of the KLIC Score: A Multicenter Study of Four Hundred Fifty-Five Patients

    Surgical Infections, Vol. 23, Núm. 3, pp. 280-287

2021

  1. Executive summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and of the Spanish Association of Surgeons (AEC) in antibiotic prophylaxis in surgery

    Cirugia Espanola, Vol. 99, Núm. 1, pp. 11-26

  2. Executive summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and of the Spanish Association of Surgeons (AEC) in antibiotic prophylaxis in surgery

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 1, pp. 29-40

  3. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  4. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

  5. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: Protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)

    Trials, Vol. 21, Núm. 1

2019

  1. Erratum to “Spanish Clinical Guidelines on Vascular Access for Haemodialysis” [(NEFROLOGÍA) (2019) 39(1) (1–2), (S0211699518301048), (10.1016/j.nefro.2018.07.001)]

    Nefrologia

  2. Erratum: Fe de errores de «Guía Clínica Española del Acceso Vascular para Hemodiálisis» (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (2017) 37 Suppl 1 (1-191) PII: S0211-6995(18)30104-8)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

2017

  1. Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae

    Scientific Reports, Vol. 7, Núm. 1

  2. Spanish Clinical Guidelines on Vascular Access for Haemodialysis

    Nefrologia, Vol. 37, pp. 1-191

2012

  1. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: A matched case-control study

    Clinical Infectious Diseases, Vol. 54, Núm. 3, pp. 355-361